Breast Implant–Associated Malignancies: Current Recommendations for Workup and Management | Journal CME-Journal CME Article: Breast Implant–Associated Malignancies: Current Recommendations for Workup and Management (Video)

Journal CME Article: Breast Implant–Associated Malignancies: Current Recommendations for Workup and Management (Video)

Video Transcription

Video Summary

BIA-SCC is a rare, aggressive squamous cancer arising in the capsule around breast implants, often after many years and commonly presenting with breast swelling, pain, redness, or seroma. Diagnosis begins with history, exam, ultrasound, aspiration, and pathology markers such as CK5/6 and p63; MRI helps define extent. Surgery is the main treatment: complete implant removal, total capsulectomy, and wide margins, sometimes requiring rib or chest wall resection with reconstruction. Chemotherapy and radiation have limited benefit. Early recognition is critical because delayed diagnosis has a high mortality risk.

Keywords

breast implant-associated squamous cell carcinoma

BIA-SCC

capsulectomy

breast swelling

early diagnosis